Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuraxis (NRXS) Change in Receivables (2022 - 2025)

Neuraxis (NRXS) has disclosed Change in Receivables for 4 consecutive years, with $87325.0 as the latest value for Q4 2025.

  • Quarterly Change in Receivables fell 50.46% to $87325.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$46589.0 through Dec 2025, down 126.05% year-over-year, with the annual reading at -$46589.0 for FY2025, 126.05% down from the prior year.
  • Change in Receivables hit $87325.0 in Q4 2025 for Neuraxis, up from -$17814.0 in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $185299.0 in Q1 2023 to a low of -$169135.0 in Q4 2022.
  • Historically, Change in Receivables has averaged $224.57 across 4 years, with a median of -$9362.0 in 2025.
  • Biggest five-year swings in Change in Receivables: soared 537.22% in 2024 and later crashed 282.95% in 2025.
  • Year by year, Change in Receivables stood at -$169135.0 in 2022, then skyrocketed by 76.16% to -$40314.0 in 2023, then skyrocketed by 537.22% to $176262.0 in 2024, then crashed by 50.46% to $87325.0 in 2025.
  • Business Quant data shows Change in Receivables for NRXS at $87325.0 in Q4 2025, -$17814.0 in Q3 2025, and -$115190.0 in Q2 2025.